Roots and Research with Manjiri: Same Cancer, Same Stage, Different Terrain: Why Two People Never Heal the Same Way

Same Cancer, Same Stage, Different Terrain:  Why Two People Never Heal the Same Way 

"But we have the exact same diagnosis. Same stage, same subtype, even the same chemo  protocol. Why is her recovery so much smoother than mine?" 

I hear a version of this question often, usually from someone in my practice who has just  compared notes with another patient in the waiting room, an online support group, or a family  member going through treatment at the same time. And it's a fair question. On paper, their  cancers look identical. In the body, they are not living through the same disease at all. 

That gap is not in your head, and it is not a matter of who is "fighting harder." It comes down to  terrain — the internal ecosystem your cancer is growing in and your treatment is working  within. Two people can share a tumor's exact molecular profile and still be standing on  completely different ground. 

The tumor is not the whole story 

Oncology, understandably, focuses first on the tumor: its stage, its receptor status, its genomic  markers, the protocol that matches those findings. That work is essential, and it is not something  integrative oncology nutrition or Ayurveda replaces. 

But the tumor doesn't exist in isolation. It exists inside a body with its own blood sugar patterns,  its own inflammatory load, its own microbiome, its own stress physiology, its own detoxification  capacity. That surrounding internal environment — the terrain — shapes how the disease  behaves, how well the body tolerates treatment, and how fully it can repair afterward. Two  identical tumors planted in two different terrains will not follow identical paths. 

This is the piece I spend most of my clinical time on: not replacing oncology care, but nourishing  and stabilizing the terrain that oncology care has to work within. 

Meet the Terrain Ten 

In my practice, and in the integrative oncology training, I use a model called the Terrain Ten™  by Dr. Nasha Winters, an approach that focuses on ten interconnected systems that influence  cancer risk, treatment tolerance, and recovery: 

1. Genetics, epigenetics & nutrigenomics — the genes you were born with, and which  ones get switched on or off by diet, stress, and environment 

2. Blood sugar balance — how stable your glucose and insulin patterns are, day to day 3. Blood circulation & oxygenation — how well oxygen and nutrients actually reach your  tissues 

4. Mental & emotional well-being — the nervous system state you're living in most days

5. Immune system — your body's surveillance and repair capacity 

6. Inflammation — how much low-grade, chronic inflammation is running in the  background 

7. Toxic burden — the load your liver and detox pathways are managing

8. Hormone balance — the interplay of the hormones that influence tissue growth

9. Stress & biorhythms — cortisol patterns, circadian rhythm, sleep quality

10. Microbiome health — the state of the bacteria living in your gut 

No two people score the same across all ten. One person's biggest terrain factor might be blood  sugar instability and insulin resistance. Another's might be a disrupted microbiome from years of  antibiotic use, or a nervous system stuck in chronic stress mode from caregiving and financial  pressure. Someone else may be carrying a heavier toxic burden, or genetic variants that affect  how they process and clear certain compounds. 

Same diagnosis. Same stage. Ten different starting points. That's why identical treatment  protocols can produce such different lived experiences. 

Why this matters most during treatment 

Chemotherapy, radiation, surgery, and hormone therapy are all, by design, demanding on the  body. They ask the terrain to do a great deal of work at once: clear damaged cells, repair tissue,  manage inflammation, keep the gut lining intact, keep blood sugar steady even as appetite and  activity change, and keep the nervous system regulated enough to sleep and eat. 

A terrain that is already under strain in one or more of these ten areas going into treatment has  less reserve to draw on. This is not about blame, nobody chooses a fragile terrain but it is useful  information, because unlike the genetic mutations driving a tumor, most terrain factors can be  supported and shifted, often meaningfully, within weeks. 

From an Ayurvedic lens, this maps closely to what we call agni (digestive and metabolic fire)  and ojas (the body's reserve of vitality and resilience). Treatment consumes ojas quickly. The  work of nutrition during cancer care is, in large part, the work of protecting agni so the body can  keep absorbing what it needs, and rebuilding ojas so there is something left in reserve to heal  with. 

What "feeding the terrain" actually looks like 

This is not a single protocol or a list of "anti-cancer foods." It's individualized, and it shifts with  each of the ten factors — but some principles show up across nearly every case I work with: 

Steadying blood sugar, gently. Cancer cells are metabolically opportunistic, and treatment side  effects (steroids, reduced activity, appetite changes) can push glucose and insulin patterns off  balance. Regular meals with protein that do not throw off your insulin and the correct form of fiber, rather than long gaps or reliance on liquid nutrition alone, help keep this steadier —  without demanding restrictive eating during a time the body is already under stress. 

Protecting the gut microbiome. Chemotherapy and antibiotics can significantly disrupt gut  flora, which in turn affects immune function, inflammation, and even how some medications are  metabolized. Fermented foods, adequate fiber as tolerated, and targeted probiotic support (timed  around treatment, not against medical advice) are part of this picture. 

Keeping inflammation in view. Some inflammation is a normal, needed part of healing after  surgery or treatment. Chronic, low-grade inflammation from diet, poor sleep, or unresolved stress  is a different matter, and it's one of the more responsive terrain factors — often improving within  a few weeks of consistent changes to food, sleep, and stress patterns. 

Supporting detoxification pathways without overloading them. The liver is doing significant  work processing treatment medications. This is a season for supporting it with adequate protein,  hydration, and key nutrients — not for aggressive "detox" protocols or high-dose supplement  stacking, which can do more harm than good during active treatment. 

Regulating the nervous system. Chronic stress and poor sleep elevate cortisol, which affects  blood sugar, immune function, and inflammation — three other terrain factors, all at once.  Simple, sustainable practices — even five to ten minutes of breathwork, a consistent wake time,  or a wind-down routine — can meaningfully shift this over time. 

Working with genetics, not against them. Nutrigenomic variants (in genes like MTHFR,  COMT, or those affecting hormone metabolism) don't determine outcomes on their own, but they  can inform which nutrients, forms, and doses make sense for a given person — one more reason  two "identical" cases may need different nutrition strategies.

What this is, and what it isn't 

I want to be direct about something important: nutrition and terrain work are not a treatment for  cancer, and no food, supplement, or protocol I recommend is positioned as one. The oncology  team's diagnosis, staging, and treatment plan remain the foundation of care, and any nutrition or  supplement strategy should be reviewed with that team, particularly around potential interactions  with chemotherapy, radiation, or hormone therapy. 

What terrain-informed nutrition can do is support the body carrying the diagnosis — helping it  tolerate treatment better, recover more fully afterward, and rebuild a stronger foundation for the  years beyond active treatment. That support looks different for every person, because every  terrain is different, even when the diagnosis on the chart reads the same. 

If you or someone you love is navigating cancer treatment or life after it, and you're wondering  what your own terrain needs, that's exactly the conversation I have with clients — mapping the  ten factors as they show up for you specifically, not as a generic checklist.

You can book a one-on-one consultation through the Bluewater Nutrition Clinic website or  by calling the clinic directly. 

About the Author 

Manjiri Nadkarni, BAMS, MD (Ayurveda), RHN, NNCP, ONC™, is an Ayurvedic physician and  oncology nutrition consultant at Bluewater Nutrition Clinic in Sarnia, Ontario, seeing clients in  person and virtually across Canada. She brings 15+ years of integrative clinical experience  spanning India and Canada, and is completing advanced certification in integrative metabolic  oncology under Dr. Nasha Winters. She is faculty in the Ayurveda Practitioner Program at  Southern California University of Health Sciences and co-founder of the Ayurveda Association  of Canada. 

This article is for general educational purposes and does not constitute individual medical  advice, diagnosis, or treatment. It is not a substitute for care from your oncology team. Always  consult your physician or oncologist before making changes to your diet, supplements, or  treatment plan, particularly during active cancer treatment. 

References 

1. Seyfried, T.N., et al. "Cancer as a metabolic disease: implications for novel therapeutics."  Carcinogenesis, 2014. 

2. Winters, N., & Kelley, J.J. The Metabolic Approach to Cancer. Chelsea Green Publishing,  2017. 

3. Zitvogel, L., et al. "Anticancer effects of the microbiome and its products." Nature  Reviews Microbiology, 2017. 

4. Coussens, L.M., & Werb, Z. "Inflammation and cancer." Nature, 2002. 5. Giovannucci, E., et al. "Diabetes and cancer: a consensus report." CA: A Cancer Journal  for Clinicians, 2010. 

6. Reiche, E.M., Nunes, S.O., & Morimoto, H.K. "Stress, depression, the immune system,  and cancer." The Lancet Oncology, 2004. 

7. Ligibel, J.A., et al. "Exercise, diet, and weight management during cancer treatment:  ASCO guideline." Journal of Clinical Oncology, 2022.